FEATURED SPEAKERS

June 23 (Sun)

Myeloid Malignancy

Keon-Hee Yoo, MD, PhD

Professor, Department of Pediatrics
Samsung Medical Center, Sungkyunkwan University School of Medicine (Korea)

Prof. Keon-Hee Yoo is a distinguished specialist in paediatric hematology and haematopoietic cell transplantation (HCT). He will give an overview of the current status and strategy of HCT for myeloid malignancies.

Lei Yu

CAR-T

Lei Yu, MD, PhD

Professor and Director, The institute for Biomedical Engineering and Technology
East China Normal University (China)

Prof. Lei Yu is the Founder of Shanghai Unicar-Therapy Inc which is the leading enterprise of CAR-T technology innovation in China, and has successfully carried out CAR-T clinical research on more than 1,000 patients with haematological tumours and solid tumours.

Yoshiyuki Takahashi

CAR-T

Yoshiyuki Takahashi, MD, PhD

Professor, Department of Pediatrics
Nagoya University (Japan)

Prof. Yoshiyuki Takahashi has developed an original CAR-T cell therapy using the Piggy-Bac transposon method on an academic basis, and has applied it clinically in Japan and Southeast Asia.

Paul D. Losty

Surgery

Paul D. Losty, MD FRCSI FRCS FRCS FRCS FEBPS
Professor, Paediatric Surgery

Alder Hey Children’s Hospital (UK)

Prof. Paul D. Losty is a distinguished leader in the field of
paediatric Surgery. He also plays a significant role as the
President of the International Society of Pediatric Surgical
Oncology (IPSO). He also serves a volunteer surgeon with
Operation Child Life, providing surgical health care to low and middle income world countries.

Chan Hon Chui

Surgery

Chan Hon Chui, FRCS, MBBS

Consultant Paediatric Surgeon
Mount Elizabeth Hospital (Singapore)

Dr. Chan Hon Chui is a paediatric surgeon with a special
interest in surgical oncology especially in neuroblastoma.
As an active member of International Society of Pediatric
Surgical Oncology (IPSO), he was its immediate past-secretary.

Melissa Hudson

Long-term Follow-up

Melissa Hudson, MD

Director, Cancer Survivorship Division
St. Jude Children’s Research Hospital (USA)

Prof. Melissa Hudson is one of the most prominent leaders of long-term follow-up for childhood cancer survivors.
She will give an overview of the current status and strategy of LTFU in the world.

Eric Bouffet

Brain Tumour

Eric Bouffet, MD

Director, Paediatric  Neuro-Oncology Program
The Hospital for Sick Children (Canada)

Prof. Eric Bouffet is one of the world leaders of paediatric neuro-oncology. His recent works include a successful clinical trial in pediatric glioma with BRAF V600 mutations. He is the Former President of SIOP and involved in development of paediatric neuro-oncology programs in low- and middle-income countries.

Ho Keung NG

Brain Tumour

Ho Keung NG, MB ChB (Edin.), MD, FRCPath, FRCPA, FCAP, FFPathRCPI, MIAC, FHKC Path

Professor, Dept of Anatomical and Cellular Pathology
Chinese University of Hong Kong (China)

Prof. H.K. Ng is a worldwide specialist in the molecular genetics of brain tumors, both in adults and peadiatrics. He is a member of the Consensus Group of WHO classifications of the brain tumours.

Rui Zhang, MD

HLH

Rui Zhang, MD

Professor, Department of Hematology
Beijing Children's Hospital (China)

Prof. Rui Zhang is one of the most prominent leaders of
HLH in China. She will give a lecture regarding the
treatment strategy of HLH in China.

Teh Kok Hoi

HLH

Teh Kok Hoi, MBBS

President, Malaysian Society of Paediatric
Haematology & Oncology
Hospital Tunku Azizah (Malaysia)

Dr. Teh Kok Hoi is the leader of paediatric haematology & oncology in Malaysia. He will give an overview of the characteristics and treatment strategy of HLH in Malaysia.

Linda Abramovitz

Nursing

Linda Abramovitz, MSN, RN, CNS, BMTCN, FAAN

Adjunct Associate Clinical Professor, School of Nursing
Global Cancer Program Faculty
University of California, San Francisco (USA)

Ms Abramovitz is a recognized nurse leader and an active member of SIOP. As a clinical nurse specialist, she improves care for pediatric oncology and HSCT patients/families. Advocating for nurses globally, she focuses on raising the standard of care in low and middle-income countries and will be presenting “Building on a Decade of Achievements: SIOP Baseline Nursing Standards for Paediatric Oncology”.

Yan Yin Lim

Nursing

Yan Yin Lim, RN, MSc, BSN, Adv Dip (oncology)

Senior Nurse Manager
KK Women's and Children's Hospital (Singapore)

Ms. Yan Yin Lim specialized in paediatric oncology and hematopoietic stem cell transplantation nursing and has completed her fellowship training in Boston Children’s Hospital, USA in 2014. Beyond Singapore, she was involved in global and health outreach nursing programs and worked with nurses in the Asia Pacific region to support nursing training and education for paediatric oncology. She is currently the chair of SIOP Asia Nursing Group.

June 24 (Mon)

A/Prof Vanessa (Ness) Tyrrell

Genome Medicine

A/Prof Vanessa (Ness) Tyrrell, BSc Biomed MBA FHGSA ARCPA GAICD

Head of the Clinical Translation Research Division
Program Director of the Zero Childhood Cancer National Precision Medicine Program
Children’s Cancer Institute (Australia)

A/Prof. Vanessa Ness Tyrrell is a recognized leader for establishing and sustaining the Zero Childhood Cancer National Precision Medicine Program to support research driven clinical care in Australia. She will introduce how this program improved outcomes for children with high risk cancer utilizing comprehensive, integrated multiomic profiling.

Koichi Ichimura

Genome Medicine

Koichi Ichimura, MD, PhD

Specially Appointed Professor, Dept of Pathology
Kyorin University Faculty of Medicine (Japan)

Prof. Koichi Ichimura is an expert of molecular genetics in brain tumours. He oversees molecular analysis of paediatric brain tumours for the central diagnosis service provided by Japan Children’s Cancer Group (JCCG).

Hiroyoshi Hattori

Hereditary Tumour

Hiroyoshi Hattori, MD, PhD

Director, Department of Clinical Genetics
Nagoya Medical Center (Japan)

Dr. Hiroyoshi Hattori is a distinguished researcher specializing in hereditary tumours, particularly Li-Fraumeni syndrome, as a core member of the Hereditary Tumuor Committee of Japan Children’s Cancer Group (JCCG).

Kris Ann P. Schultz

Hereditary Tumour

Kris Ann P. Schultz, MD

Scientific Director, Cancer and Blood Disorders
Children's Minnesota (USA)

Dr. Kris Ann P. Schultz is a world leader in the field of cancer predisposition through her work on DICER1 mutations, and is the first author of the Blueprint for Rare Tumours by COG.

Joanne Ngeow Yuen Yie

Hereditary Tumour

Joanne Ngeow Yuen Yie, MBBS, MRCP, MMed, FAMS, MPH

Senior Consultant, Division of Medical Oncology
National Cancer Centre Singapore (Singapore)

Assoc Prof. Joanne Ngeow Yuen Yie currently heads the Cancer Genetics Service at the National Cancer Centre Singapore with an academic interest in hereditary cancer syndromes and translational clinical cancer genetics.

Motohiro Kato

Hereditary Tumour

Motohiro Kato, MD, PhD

Professor, Department of Paediatrics
The University of Tokyo (Japan)

Prof. Motohiro Kato chairs the ALL Committee in Japan Children’s Cancer Group (JCCG). He leads research and clinical practice of paediatric leukemia in Japan, and is also a prominent specialist in cancer genomics.

Elena Ladas

Nutrition Symposium

Elena Ladas PhD, RD

Co-Director, Center for Comprehensive Wellness
Columbia University Irving Medical Center (USA)

Dr. Elena Ladas research contributes to the role of nutrition and childhood cancer and enhance nutritional capacity in pediatric cancer units in low- and middle-income countries.

Greg Wheeler

Radiation Oncology

Greg Wheeler, MD

Chair, Paediatric and Late Effects Service
Dept. of Radiation Oncology
Peter Maccallum Cancer Centre (Australia)

Dr. Greg Wheeler is one of the leaders in late effects after radiotherapy. He will give a lecture on a strategy of follow-up from the radiation oncologist’s point of view.

Greg Wheeler

Nursing

Ayda Gan Nambayan, RN PhD

Consultant
The Ruth Foundation for Palliative and Hospice Care (Philippines)

Dr. Ayda Gan Nambayan is currently a consultant at the The Ruth Foundation for Palliative and Hospice Care. Prior experiences include being the curriculum developer for www.CureKids.org of St. Jude Children’s Research Hospital and a faculty for the School of Nursing and an associate scientist at the University of Alabama at Birmingham. She will be presenting “Family-Centered Care in End-of-life Decision-Making”.

Greg Wheeler

Nursing Special Lecture

Josef Gohori, PhD

Doctor of Philosophy
Graduate School of Integrated Human Welfare
Shukutoku University (Japan)

Prof. Josef Gohori is an anthropologist, focusing on medical care and social work. He coordinates an international joint research project on Buddhist social work in the Asian region, focusing on the cultural background of social work practice and education, specifically on the role of religion and spirituality. He will speak about "Life" from the Buddhist perspective: Exploring the Cultural Background of Nursing and Care.

June 25 (Tue)

Hiroki Hori

International Collaboration

Hiroki Hori, MD, PhD

Director of Pediatrics
Mie University (Japan)

Prof. Hiroki Hori is the SIOP Asia President, and is well known for his great contribution regarding international collaboration throughout Asia.

Mariko Kakazu

International Collaboration

Mariko Kakazu, MD

Director of Pediatrics
Japan Heart Children’s Medical Center (Cambodia)

Dr. Mariko Kakazu is well known for her sincere dedication to have launched a medical clinic for cancer children in Cambodia, and have provided free medical service for children there.

Siddhartha Laskar

Radiation Oncology 2

Siddhartha Laskar, MD

Professor, Dept. of Radiation Oncology
Tata Memorial Hospital (India)

Prof. Siddhartha Laskar is one of the pioneers in brachytherapy for paediatric sarcoma. He will give a lecture on his experience in the rare radiation treatment.

PageTop